For patients classified as obese, with a body mass index (BMI) of 30 or higher, or those who are overweight with a BMI of 27 or higher and have additional weight-related health conditions, Ozempic may be considered as part of a comprehensive treatment plan
Qsymia (phentermine/topiramate) is FDA-approved for chronic weight management in adults and children with obesity, or overweight and a weight-related health condition
Longitudinal validation over 4.6 years confirmed its clinical utility: patients classified by DeepDKD as having isolated diabetic nephropathy showed slower eGFR decline (27.45%) compared to those classified as NDKD (52.56%) (Meng et al., 2025)
Correct storage of GLP-1 receptor agonists is critical to preserve the structural integrity of these peptide-based medications
However the often ignored dark side of methionine is that it is toxic in high amounts
In five patients, the symptoms improved with the reduction of the GLP-1 RA dose, and the remaining eleven discontinued treatment